Header cover image

Japanese (NIKKEI) Biotech Industry Analysis

UpdatedDec 21, 2024
DataAggregated Company Financials
Companies33
  • 7D-1.7%
  • 3M-8.4%
  • 1Y18.5%
  • YTD12.1%

Over the last 7 days, the Biotech industry has dropped 1.7%, driven by PeptiDream declining 4.6%. In contrast, Heartseed has gained 26%. Over the past 12 months, the industry was up 19%. As for the next few years, earnings are expected to grow by 13% per annum.

Industry Valuation and Performance

Has the Japanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 22 Dec 2024JP¥1.0tJP¥206.4b-JP¥12,718,809,000.0022.4x-82x5.1x
Tue, 19 Nov 2024JP¥1.0tJP¥207.4b-JP¥10,788,549,000.0019.5x-94x4.9x
Thu, 17 Oct 2024JP¥1.1tJP¥214.3b-JP¥3,905,356,000.0022x-283.1x5.2x
Sat, 14 Sep 2024JP¥1.0tJP¥210.1b-JP¥469,229,000.0018.5x-2217.7x5x
Mon, 12 Aug 2024JP¥948.4bJP¥213.8bJP¥1.8b13.9x516.5x4.4x
Wed, 10 Jul 2024JP¥1.0tJP¥187.7b-JP¥15,773,047,000.0092.2x-64.3x5.4x
Fri, 07 Jun 2024JP¥814.3bJP¥195.7b-JP¥14,113,284,000.0095.9x-57.7x4.2x
Sun, 05 May 2024JP¥801.3bJP¥199.1b-JP¥14,617,545,000.0077.4x-54.8x4x
Tue, 02 Apr 2024JP¥764.7bJP¥194.2b-JP¥15,458,035,000.0060.9x-49.5x3.9x
Thu, 29 Feb 2024JP¥869.9bJP¥196.2b-JP¥19,179,997,000.0068.2x-45.4x4.4x
Sat, 27 Jan 2024JP¥779.2bJP¥222.3b-JP¥12,604,827,000.0017.6x-61.8x3.5x
Mon, 25 Dec 2023JP¥773.1bJP¥224.2b-JP¥12,970,409,000.0016.8x-59.6x3.4x
Wed, 22 Nov 2023JP¥796.0bJP¥221.9b-JP¥12,426,487,000.0017.2x-64.1x3.6x
Fri, 20 Oct 2023JP¥751.6bJP¥223.0b-JP¥14,478,735,000.0021.1x-51.9x3.4x
Sun, 17 Sep 2023JP¥886.1bJP¥225.3b-JP¥16,963,735,000.0027.6x-52.2x3.9x
Tue, 15 Aug 2023JP¥852.1bJP¥219.4b-JP¥18,857,181,000.0049.6x-45.2x3.9x
Thu, 13 Jul 2023JP¥913.5bJP¥223.0b-JP¥19,224,669,000.0053.5x-47.5x4.1x
Sat, 10 Jun 2023JP¥967.6bJP¥220.6b-JP¥21,578,670,000.0046.3x-44.8x4.4x
Mon, 08 May 2023JP¥892.4bJP¥218.2b-JP¥20,061,938,000.0020.8x-44.5x4.1x
Wed, 05 Apr 2023JP¥929.3bJP¥218.3b-JP¥21,583,164,000.0021.6x-43.1x4.3x
Fri, 03 Mar 2023JP¥904.8bJP¥216.2b-JP¥18,991,580,000.0020.3x-47.6x4.2x
Sun, 29 Jan 2023JP¥949.5bJP¥186.7b-JP¥24,854,541,000.0039.7x-38.2x5.1x
Tue, 27 Dec 2022JP¥865.0bJP¥186.8b-JP¥24,723,433,000.0038.7x-35x4.6x
Thu, 24 Nov 2022JP¥903.6bJP¥182.1b-JP¥23,614,604,000.0048.1x-38.3x5x
Sat, 22 Oct 2022JP¥836.0bJP¥176.5b-JP¥24,974,270,000.0046.4x-33.5x4.7x
Mon, 19 Sep 2022JP¥897.0bJP¥176.5b-JP¥24,974,270,000.0046.8x-35.9x5.1x
Wed, 17 Aug 2022JP¥977.1bJP¥172.9b-JP¥21,066,889,000.0021.3x-46.4x5.7x
Fri, 15 Jul 2022JP¥952.3bJP¥171.3b-JP¥16,112,943,000.0022x-59.1x5.6x
Sun, 12 Jun 2022JP¥900.5bJP¥171.2b-JP¥17,280,721,000.0023.3x-52.1x5.3x
Tue, 10 May 2022JP¥963.6bJP¥163.9b-JP¥13,145,184,000.0013.8x-73.3x5.9x
Thu, 07 Apr 2022JP¥1.1tJP¥164.2b-JP¥13,043,295,000.0014.9x-85.5x6.8x
Sat, 05 Mar 2022JP¥1.1tJP¥159.9b-JP¥9,023,798,000.0014.9x-117.8x6.6x
Mon, 31 Jan 2022JP¥985.4bJP¥163.5b-JP¥5,447,358,000.0015.4x-180.9x6x
Wed, 29 Dec 2021JP¥1.2tJP¥163.5b-JP¥5,447,524,000.0018.1x-224.1x7.5x
Price to Earnings Ratio

-224.1x


Total Market Cap: JP¥1.2tTotal Earnings: -JP¥5,447,524,000.00Total Revenue: JP¥163.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Biotech Industry Price to Earnings3Y Average -134.7x202220232024
Current Industry PE
  • Investors are relatively neutral on the Japanese Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 4.8x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 8.1% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare industry?

JP Market-1.46%
Healthcare-0.72%
Biotech-1.73%
Biotech-1.73%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
219A HeartseedJP¥2.45k26.1%
+JP¥11.2b
n/an/a
2160 GNI GroupJP¥3.22k5.8%
+JP¥8.8b
14.5%PE22.4x
4576 D. Western Therapeutics InstituteJP¥225.00116.3%
+JP¥4.6b
63.0%PS18.4x
190A Chordia TherapeuticsJP¥307.0020.4%
+JP¥3.5b
n/aPB5x
7777 3-D MatrixJP¥146.0022.7%
+JP¥2.7b
7.4%PS2.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

7776

JP¥410.00

CellSeed

7D

-12.8%

1Y

57.7%

4599

JP¥305.00

StemRIM

7D

-7.0%

1Y

-44.2%

4592

JP¥757.00

SanBio

7D

-16.4%

1Y

4.8%

219A

JP¥2,448.00

Heartseed

7D

26.1%

1Y

n/a

2929

JP¥926.00

Pharma Foods International

7D

3.6%

1Y

-6.0%

4587

JP¥2,570.00

PeptiDream

7D

-4.6%

1Y

94.8%

4598

JP¥677.00

Delta-Fly Pharma

7D

7.5%

1Y

-22.0%

4576

JP¥225.00

D. Western Therapeutics Institute

7D

116.3%

1Y

63.0%

2160

JP¥3,215.00

GNI Group

7D

5.8%

1Y

14.5%

4891

JP¥219.00

TMS

7D

6.3%

1Y

29.6%

4564

JP¥24.00

OncoTherapy Science

7D

-22.6%

1Y

26.3%